Publications

The GW Regulatory Studies Center scholars regularly conduct applied research to understand regulatory policy and practice from a public interest perspective. Our content often takes the form of public interest comments, formal testimony, working papers, policy insights, and short commentaries analyzing the most pressing issues in regulatory policy. View the rest of our material by the different types of publications listed on this page or our research areas.

Browse All Publications

What We Publish

Long-form publications intended for academic audiences that take a deep dive into a particular aspect of regulatory policy.

Scholarly analysis of the potential effects of particular rulemakings from federal agencies, and advice to Congress on how to improve the rulemaking process.

Short-form publications intended for all audiences which provide easy to access analysis of regulatory policy.

Formal publications, often completed with other leading organizations and individuals, providing a thorough understanding of regulations and the rulemaking process.

The weekly Regulation Digest contains everything you need to know about regulatory policy today, and our monthly Center Update gives you all of the latest from our team.

For accessible charts and supporting data that you can use in your own publications or presentations, visit the Reg Stats page.

Latest Publications

ACUS Publishes Draft Recommendations to Improve the Congressional Review Act

November 9, 2021

A new project at the Administrative Conference of the United States will consider technical reforms to the Congressional Review Act. The recently-issued draft report is an excellent primer on the details of regulatory agency and congressional staff implementation of the CRA. It provides a deep dive analysis of several policy options available to Congress to improve the CRA. ACUS is going through its process to develop draft recommendations now.

Extending Pandemic Flexibilities for Opioid Use Disorder Treatment

November 2, 2021

This Essay evaluates two specific flexibilities granted during the COVID-19 pandemic that made it easier for patients to access buprenorphine and methadone. First, the Drug Enforcement Administration (DEA) allowed practitioners to prescribe buprenorphine using telemedicine without first conducting an in-person medical exam.

What is the Congressional Review Act?

November 1, 2021

Unpacking the OECD Recommendation on Agile Regulatory Governance

October 27, 2021

On October 6, the OECD Council adopted a Recommendation at the ministerial level related to agile regulatory governance. The Recommendation is designed to help governments consider regulatory structures that best bolster innovation in their countries. Overall, this Recommendation signals that the OECD sees regulation focused on promoting innovation as valuable—particularly in light of the rapidly-evolving nature of emerging technologies.

Benefits of a Rowdy Bureaucracy

October 26, 2021

Professor Andrew Rudalevige's book introduces us to a core idea: the executive branch matters to executive orders.

Bridget Dooling Cited in Draft Report for ACUS

October 26, 2021

What’s the Status of the Biden Administration’s Workplace Vaccine Mandate?

October 21, 2021

The workplace vaccine mandate faces steep legal and practical challenges, but the president’s announcement may still help drive up vaccination rates.

Notice and Comment Policymaking in China

October 20, 2021

This commentary examines how the notice and comment process in Guangzhou has changed.

Diffusion or Abandonment?

October 12, 2021

The notice and comment process is a prominent governance reform in contemporary China.

OIRA the Angel; OIRA the Devil

October 8, 2021

In their most recent book, Reviving Rationality, Mike Livermore and Ricky Revesz build on their record of support for the use of analytical tools, particularly cost-benefit analysis, to evaluate rules prior to their issuance.